Lipodystrophy in 685 HIV-1-treated patients: influence of antiretroviral treatment and immunovirological response.

Boufassa, F; Dulioust, A; Lascaux, A S; Meyer, L; Boué, F; Delfraissy, J F; Sobel, A; Goujard, C

Boufassa, F; Dulioust, A; Lascaux, A S; Meyer, L; Boué, F; Delfraissy, J F; Sobel, A; Goujard, C.

Affiliation

Boufassa F; Department of Epidemiology, INSERM U292, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France. boufassa@vjf.inserm.fr

HIV Clin Trials ; 2(4): 339-45, 2001.

Article in En | MEDLINE | ID: mdl-11590538

Subject(s)

Anti-HIV Agents/adverse effects; HIV Infections/drug therapy; Lipodystrophy/chemically induced; Lipodystrophy/epidemiology; Reverse Transcriptase Inhibitors/adverse effects; Adult; Cross-Sectional Studies; Drug Therapy, Combination; Female; HIV-1/isolation & purification; Humans; Male; RNA, Viral/blood; Risk Factors

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Reverse Transcriptase Inhibitors / Anti-HIV Agents / Lipodystrophy Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: HIV Clin Trials Year: 2001 Document type: Article

Search on Google

XML

PubMed Links